Skip to main content
Clinical Trials/NCT06622889
NCT06622889
Enrolling by Invitation
N/A

The Effectiveness of Interventions Targeting Self-Perception of Aging in Older Adults with Subjective Cognitive Decline

Zheng Li1 site in 1 country64 target enrollmentNovember 1, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Subjective Cognitive Decline (SCD)
Sponsor
Zheng Li
Enrollment
64
Locations
1
Primary Endpoint
Subjective Cognitive Decline
Status
Enrolling by Invitation
Last Updated
last year

Overview

Brief Summary

Subjective cognitive decline (SCD) represents the initial clinical manifestation in the disease spectrum of Alzheimer's Disease (AD). It represents an essential stage for early prevention and treatment of cognitive impairment, making the SCD population an optimal target for prior intervention. This study aims to assess the feasibility and efficacy of an 8-week intervention targeting self-perception of aging in community-dwelling older adults with SCD.

Detailed Description

Dementia, especially Alzheimer's Disease (AD), is a major healthcare issue in aging populations. It not only threatens the physical and mental health of older adults but also imposes significant economic and caregiving burdens on families and society. As a preclinical stage of AD, subjective cognitive decline (SCD) is regarded as the optimal phase for early intervention in cognitive impairment. When confronted with the threats of physical, psychological, and social aging, older adults with SCD often hold negative perceptions and emotional responses toward their own aging. They tend to attribute physical decline and memory loss to normal aging processes, overlooking controllable factors, which poses potential risks to their future cognitive outcomes, such as accelerated cognitive decline, elevated dementia risk, and increased accumulation of AD biomarkers. This study is based on the Transactional Model of Stress and Coping (TMSC) and identifies the mechanisms through which self-perception of aging influences cognitive function in older adults with SCD. A comprehensive 8-week intervention program was developed to target these mechanisms. The 8-week intervention program aims to provide practical evidence for delaying cognitive decline in older adults with SCD by enhancing their positive perceptions of aging.

Registry
clinicaltrials.gov
Start Date
November 1, 2024
End Date
June 30, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Zheng Li
Responsible Party
Sponsor Investigator
Principal Investigator

Zheng Li

Professor

Peking Union Medical College

Eligibility Criteria

Inclusion Criteria

  • aged ≥60 years;
  • residing in the community for 6 months at least;
  • experiencing a consistent decline in self-reported cognitive abilities;
  • having standard cognitive test performance in the normal range;
  • willing to participate in this study.

Exclusion Criteria

  • having diagnosis of any neurological diseases including Parkinson's disease, brain tumor, cerebral infarction, encephalitis, epilepsy, etc.;
  • having diagnosis of mental illness such as depression, anxiety, bipolar disorder, and schizophrenia;
  • with history of substance abuse or addiction;
  • with severe visual or hearing impairment.

Outcomes

Primary Outcomes

Subjective Cognitive Decline

Time Frame: Baseline (pre-intervention),8 weeks (post-intervention),and 16 weeks (follow-up)

The 9-item Subjective Cognitive Decline Questionnaire (SCD-Q9) consists of 9 items. Higher scores indicate a greater likelihood of subjective cognitive impairment.

Secondary Outcomes

  • Cognitive Function(Baseline (pre-intervention),8 weeks (post-intervention),and 16 weeks (follow-up))
  • Self-perception of Aging(Baseline (pre-intervention),8 weeks (post-intervention),and 16 weeks (follow-up))
  • Perceived Stress(Baseline (pre-intervention),8 weeks (post-intervention),and 16 weeks (follow-up))
  • Coping Strategies(Baseline (pre-intervention),8 weeks (post-intervention),and 16 weeks (follow-up))

Study Sites (1)

Loading locations...

Similar Trials